CDC Launches Opioid Prescribing Guideline Resources for Providers

Dec 16, 2016 - 05:24 AM

This week, the CDC launched a suite of new opioid prescribing guideline resources for providers, including a mobile app and video series. This is a follow-up to their CDC Guideline for Prescribing Opioids for Chronic Pain, launched last spring, to encourage safer and more effective pain management. 

According to the CDC, “The new Opioid Guide App makes it easier to apply the recommendations in the CDC Guideline for Prescribing Opioids for Chronic Pain into clinical practice by putting the entire guideline, tools and resources in the palm of your hand.” 

The free mobile app, available for Apple and Android devices, features:

  • A Morphine Milligram Equivalent (MME) Calculator
  • Prescribing Guidance
  • Motivational Interviewing (MI) feature to practice effective communication skills

In addition to the app, CDC has developed a video series to help improve understanding about prescription opioids to encourage communication between clinicians and patients. An example of the videos, Even When Prescribed by a Doctor, raises general awareness about opioids and can be shared on social media or used in training sessions or presentations. 

The data suggests there is more work to do, and we stand with our partners and stakeholders to deliver impact. For more information on how the AHA is addressing the opioid abuse crisis, visit: aha.org/behavioralhealth/opioids. To access CDC’s tools and resources, visit: cdc.gov/drugoverdose/prescribing/resources.html.  

Related News Articles

Headline
Overdose deaths dropped an estimated 27% in 2024
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
AHA makes 100 suggestions to Trump administration on providing regulatory relief 
The AHA May 12 responded to the Office of Management and Budget's April 11 request for information on regulatory relief, making 100 suggestions to the Trump…
Headline
FDA announces recall for certain IV bags
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
Recall issued for aspiration system by Q’Apel Medical
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
FDA issues alerts on certain catheters produced by BD, Conavi
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…
Headline
AHA launches online collaborative focused on quality improvement
The AHA Living Learning Network is launching the Quality Exchange, a virtual collaborative for health care quality and patient safety professionals at…